SUPPORT SERVICES FOR MEN TAKING NUBEQA

Access Services by Bayer™ is here to help

with a range of services and resources to support you, including:

NUBEQA (darolutamide) support services include access to a nurse, insurance assistance, and financial assistance

Assistance to help you understand your insurance benefits for NUBEQA

NUBEQA (darolutamide) support services include access to a nurse, insurance assistance, and financial assistance

Access to a nurse who can answer treatment questions

NUBEQA (darolutamide) support services include access to a nurse, insurance assistance, and financial assistance

Assistance with insurance coverage barriers

NUBEQA (darolutamide) support services include access to a nurse, insurance assistance, and financial assistance

Connecting you with financial assistance to help pay for NUBEQA

ACCESS SERVICES BY BAYER IS HERE TO HELP FIND THE NUBEQA FINANCIAL ASSISTANCE THAT IS RIGHT FOR YOU

1

MONTH FREE

NUBEQA FREE TRIAL PROGRAM

Patients who are NEW to NUBEQA can get 1 month of free medication.*

Access Services by Bayer™

To find out more about how these programs and other support services can help, call Access Services by Bayer

1-800-288-8374

MONDAY‐FRIDAY:
9:00 AM‐6:00 PM (ET)

*The NUBEQA Free Trial Program provides 1 month's supply of NUBEQA at no cost to patients who meet the program eligibility requirements and agree to the terms and conditions. For full terms and conditions, please call Access Services by Bayer at 1-800-288-8374.

Couple Dancing

HOW MUCH DOES NUBEQA COST?

  • 93% of men were covered for NUBEQA based on claims data provided to Bayer through April 2021

  • The average total cost of NUBEQA for men with Medicare coverage is $1082, with most men paying less than $50 in co-pay

  • The average total cost for NUBEQA for men with commercial insurance coverage is $1714, with most men paying less than $50 in co-pay

For more information and help, please review the information provided by Access Services by Bayer above.

ADDITIONAL SUPPORT AVAILABLE FOR YOU

NUBEQA co‐pay card

NUBEQA $0 CO-PAY PROGRAM

for eligible patients with insurance through an employer or insurance they have purchased themselves (also known as commercial or private insurance).†

Patient Access Specialists

REFERRALS TO CHARITABLE FOUNDATIONS

which may be able to help patients with government-sponsored insurance (such as Medicare, Medigap, Medicaid, VA/DoD health plans, and TRICARE) with out-of-pocket costs.

  • Patient Access Specialists can verify your coverage for NUBEQA and provide information about any available foundations

Free medicine for patients

REFERRALS TO BAYER US PATIENT ASSISTANCE FOUNDATION

which provides free medicine for patients who are uninsured or underinsured and meet certain eligibility criteria.‡

†Restrictions may apply. For full terms and conditions, please call Access Services by Bayer at 1-800-288-8374 or visit NUBEQAcopayprogram.com. Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, eg, co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payers of any benefits they receive and the value of this program, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Eligibility and participation are subject to review and may be modified or discontinued at any time.

‡Bayer provides NUBEQA free of charge for eligible patients who are uninsured or underinsured. In order to qualify for assistance, you must meet certain eligibility criteria.

More information Less information

INDICATION

NUBEQA® (darolutamide) is a prescription medicine used to treat men with prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

It is not known if NUBEQA is safe and effective in women and children.

IMPORTANT SAFETY INFORMATION

NUBEQA can harm unborn babies and cause loss of pregnancy. Men with female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA.

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

  • Have kidney or liver problems.
  • Have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods.
  • For women, tell your healthcare provider if you are:
    • pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
    • breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine without talking to your healthcare provider.

Most common side effects of NUBEQA include:

  • Feeling more tired than usual
  • Arm, leg, hand, or foot pain
  • Rash
  • Decreased white blood cells (neutropenia)
  • Changes in tests that determine how your liver works (liver function tests)

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 1-800-FDA-1088 or www.fda.gov/medwatch.

For important risk and use information about NUBEQA, please see the full Prescribing Information.

© 2022 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer.

Date of last update: 02/04/2022